Deficiency of senescence marker protein 30 exacerbates angiotensin II-induced cardiac remodelling

Cardiovascular Research

Volumn 99, Issue 3, 2013, Pages 461-470

  Misaka, Tomofumi ^a   Suzuki, Satoshi ^a   Miyata, Makiko ^a   Kobayashi, Atsushi ^a   Shishido, Tetsuro ^b   Ishigami, Akihito ^c   Saitoh, Shu Ichi ^a   Hirose, Masamichi ^d   Kubota, Isao ^b   Takeishi, Yasuchika ^a  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^b YAMAGATA UNIVERSITY   (Japan)

^c TOKYO METROPOLITAN INSTITUTE OF GERONTOLOGY   (Japan)

^d IWATE MEDICAL UNIVERSITY   (Japan)

Author keywords

Ageing; Apoptosis; Oxidative stress; Remodelling; Senescence marker protein 30 (SMP30)

Indexed keywords

ANGIOTENSIN II; ASCORBIC ACID; CASPASE 3; DNA NUCLEOTIDYLEXOTRANSFERASE; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P21; REACTIVE OXYGEN METABOLITE; REGUCALCIN; STRESS ACTIVATED PROTEIN KINASE; BAX PROTEIN, MOUSE; BCL2 PROTEIN, MOUSE; BIOLOGICAL MARKER; CALCIUM BINDING PROTEIN; CASP3 PROTEIN, MOUSE; RGN PROTEIN, MOUSE; SIGNAL PEPTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIAC REMODELLING; CONTROLLED STUDY; DISEASE EXACERBATION; GENE EXPRESSION; HEART; HEART CYCLE; HEART DISEASE; HEART MUSCLE FIBROSIS; HEART VENTRICLE HYPERTROPHY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFICIENCY; SENESCENCE; SENESCENCE MARKER PROTEIN 30 DEFICIENCY; TRANSTHORACIC ECHOCARDIOGRAPHY; AGING; ANIMAL; APOPTOSIS; C57BL MOUSE; CARDIOMEGALY; DISEASE MODEL; FIBROSIS; GENETICS; HEART FAILURE; HEART MUSCLE; HEART VENTRICLE REMODELING; KNOCKOUT MOUSE; METABOLISM; OXIDATIVE STRESS; PATHOLOGY; PHYSIOLOGY; REMODELLING; SENESCENCE MARKER PROTEIN 30 (SMP30); SIGNAL TRANSDUCTION; DEFICIENCY;

AGEING; APOPTOSIS; OXIDATIVE STRESS; REMODELLING; SENESCENCE MARKER PROTEIN 30 (SMP30);

AGING; ANGIOTENSIN II; ANIMALS; APOPTOSIS; ASCORBIC ACID; BCL-2-ASSOCIATED X PROTEIN; BIOLOGICAL MARKERS; CALCIUM-BINDING PROTEINS; CARDIOMEGALY; CASPASE 3; DISEASE MODELS, ANIMAL; FIBROSIS; HEART FAILURE; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYOCARDIUM; OXIDATIVE STRESS; PROTO-ONCOGENE PROTEINS C-BCL-2; SIGNAL TRANSDUCTION; VENTRICULAR REMODELING;

EID: 84894432374     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvt122     Document Type: Article

References (43)

1. Lakatta EG, Levy D. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: part II: the aging heart in health: links to heart disease. Circulation 2003;107:346-354.
2. Lakatta EG. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: part III: cellular and molecular clues to heart and arterial aging. Circulation 2003;107:490-497.
3. Wang M, Zhang J, Walker SJ, Dworakowski R, Lakatta EG, Shah AM. Involvement of NADPH oxidase in age-associated cardiac remodeling. J Mol Cell Cardiol 2010;48: 765-772.
4. Fujita T, Uchida K, Maruyama N. Purification of senescence marker protein-30 (SMP30) and its androgen-independent decrease with age in the rat liver. Biochim Biophys Acta 1992;1116:122-128.
5. Fujita T, Mandel JL, Shirasawa T, Hino O, Shirai T, Maruyama N. Isolation of cDNA clone encoding human homologue of senescence marker protein-30 (SMP30) and its location on the X chromosome. Biochim Biophys Acta 1995;1263:249-252.
6. Arun P, Aleti V, Parikh K, Manne V, Chilukuri N. Senescence marker protein 30 (SMP30) expression in eukaryotic cells: existence of multiple species and membrane localization. PLoS ONE 2011;6:e16545.
7. Shimokawa N, Yamaguchi M. Molecular cloning and sequencing of the cDNA coding for a calcium-binding protein regucalcin from rat liver. FEBS Lett 1993;327:251-255.
8. Son TG, Kim SJ, Kim K, Kim MS, Chung HY, Lee J. Cytoprotective roles of senescence marker protein 30 against intracellular calcium elevation and oxidative stress. Arch Pharm Res 2008;31:872-877.
9. Little JS, Broomfield CA, Fox-Talbot MK, Boucher LJ, MacIver B, Lenz DE. Partial characterization of an enzyme that hydrolyzes sarin, soman, tabun, and diisopropyl phosphorofluoridate (DFP). Biochem Pharmacol 1989;38:23-29.
10. Kondo Y, Inai Y, Sato Y, Handa S, Kubo S, Shimokado K et al. Senescence marker protein 30 functions as gluconolactonase in L-ascorbic acid biosynthesis, and its knockout mice are prone to scurvy. Proc Natl Acad Sci USA 2006;103:5723-5728.
11. Ishigami A, Fujita T, Handa S, Shirasawa T, Koseki H, Kitamura T et al. Senescence marker protein-30 knockout mouse liver is highly susceptible to tumor necrosis factor-alpha-and Fas-mediated apoptosis. Am J Pathol 2002;161:1273-1281.
12. Ishigami A, KondoY, Nanba R, OhsawaT, Handa S, Kubo S et al.SMP30 deficiency in mice causes an accumulation of neutral lipids and phospholipids in the liver and shortens the life span. Biochem Biophys Res Commun 2004;315:575-580.
13. Son TG, Zou Y, Jung KJ, Yu BP, Ishigami A, Maruyama N et al. SMP30 deficiency causes increased oxidative stress in brain. Mech Ageing Dev 2006;127:451-457.
14. Sato T, Seyama K, Sato Y, Mori H, Souma S, Akiyoshi T et al. Senescence marker protein-30 protects mice lungs from oxidative stress, aging, and smoking. Am J Respir Crit Care Med 2006;174:530-537.
15. Yumura W, Imasawa T, Suganuma S, Ishigami A, Handa S, Kubo S et al. Accelerated tubular cell senescence inSMP30 knockout mice. Histol Histopathol 2006;21:1151-1156.
16. Hasegawa G, Yamasaki M, Kadono M, Tanaka M, Asano M, Senmaru T et al. Senescence marker protein-30/gluconolactonase deletion worsens glucose tolerance through impairment of acute insulin secretion. Endocrinology 2010;151:529-536.
17. Xue B, Pamidimukkala J, Lubahn DB, Hay M. Estrogen receptor-alpha mediates estrogen protection from angiotensin II-induced hypertension in conscious female mice. Am J Physiol Heart Circ Physiol 2007;292:H1770-H1776.
18. Kobayashi A, Ishikawa K, Matsumoto H, Kimura S, Kamiyama Y, Maruyama Y. Synergetic antioxidant and vasodilatory action of carbon monoxide in angiotensin II-induced cardiac hypertrophy. Hypertension 2007;50:1040-1048.
19. Tsao CS, Leung PY, Young M. Effect of dietary ascorbic acid intake on tissue vitamin C in mice. J Nutr 1987;117:291-297.
20. Carlson SH, WyssJM. Long-term telemetric recording of arterial pressure and heart rate in mice fed basal and high NaCl diets. Hypertension 2000;35:E1-E5.
21. DuJ, Liu J, FengHZ, HossainMM, Gobara N, ZhangCet al. Impaired relaxation is the main manifestation in transgenic mice expressing a restrictive cardiomyopathy mutation, R193H, in cardiac TnI. Am J Physiol Heart Circ Physiol 2008;294:H2604-H2613.
22. Wilson RM, De Silva DS, Sato K, Izumiya Y, Sam F. Effects of fixed-dose isosorbide dinitrate/ hydralazine on diastolic function and exercise capacity in hypertension-induced diastolic heart failure. Hypertension 2009;54:583-590.
23. Kitahara T, Takeishi Y, Harada M, Niizeki T, Suzuki S, Sasaki T et al. High-mobility group box 1 restores cardiac function after myocardial infarction in transgenic mice. Cardiovasc Res 2008;80:40-46.
24. Arimoto T, Takeishi Y, Takahashi H, Shishido T, Niizeki T, Koyama Y et al. Cardiacspecific overexpression of diacylglycerol kinase zeta prevents Gq protein-coupled receptor agonist-induced cardiac hypertrophy in transgenic mice. Circulation 2006; 113:60-66.
25. Takimoto E, Champion HC, Li M, Ren S, Rodriguez ER, Tavazzi B et al. Oxidant stress from nitric oxide synthase-3 uncoupling stimulates cardiac pathologic remodeling from chronic pressure load. J Clin Invest 2005;115:1221-1231.
26. Machii H, Saitoh S, Kaneshiro T, Takeishi Y. Aging impairs myocardium-induced dilation in coronary arterioles: role of hydrogen peroxide and angiotensin. Mech Ageing Dev 2010; 131:710-717.
27. Matsushima S, Kinugawa S, Yokota T, Inoue N, Ohta Y, Hamaguchi S et al. Increased myocardial NAD(P)H oxidase-derived superoxide causes the exacerbation of postinfarct heart failure in type 2 diabetes. Am J Physiol Heart Circ Physiol 2009;297:H409-H416.
28. Nozaki N, Shishido T, Takeishi Y, Kubota I. Modulation of doxorubicin-induced cardiac dysfunction in toll-like receptor-2-knockout mice. Circulation 2004;110:2869-2874.
29. Dimri GP, Lee X, Basile G, Acosta M, Scott G, Roskelley C et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci USA 1995;92:9363-9367.
30. Camelliti P, Borg TK, Kohl P. Structural and functional characterisation of cardiac fibroblasts. Cardiovasc Res 2005;65:40-51.
31. Yue TL, Wang C, Romanic AM, Kikly K, Keller P, DeWolf WE Jr et al. Staurosporine-induced apoptosis in cardiomyocytes: a potential role of caspase-3. J Mol Cell Cardiol 1998;30:495-507.
32. Aoki H, Kang PM, Hampe J, Yoshimura K, Noma T, MatsuzakiMet al. Direct activation of mitochondrial apoptosis machinery by c-Jun N-terminal kinase in adult cardiac myocytes. J Biol Chem 2002;277:10244-10250.
33. Weber KT, Brilla CG. Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system. Circulation 1991;83:1849-1865.
34. Izumiya Y, Kim S, Izumi Y, Yoshida K, Yoshiyama M, Matsuzawa A et al. Apoptosis signalregulating kinase 1 plays a pivotal role in angiotensin II-induced cardiac hypertrophy and remodeling. Circ Res 2003;93:874-883.
35. Mollnau H, Wendt M, Szocs K, Lassegue B, Schulz E, OelzeMet al. Effects of angiotensin II infusion on the expression and function of NAD(P)H oxidase and components of nitric oxide/cGMP signaling. Circ Res 2002;90:E58-E65.
36. Giordano FJ. Oxygen, oxidative stress, hypoxia, and heart failure. J Clin Invest 2005; 115:500-508.
37. Olivetti G, Abbi R, Quaini F, Kajstura J, ChengW, Nitahara JA et al. Apoptosis in the failing human heart. N Engl J Med 1997;336:1131-1141.
38. Ravassa S, Fortuno MA, Gonzalez A, Lopez B, Zalba G, Fortuno A et al. Mechanisms of increased susceptibility to angiotensin II-induced apoptosis in ventricular cardiomyocytes of spontaneously hypertensive rats. Hypertension 2000;36:1065-1071.
39. Park M, Shen YT, Gaussin V, Heyndrickx GR, Bartunek J, Resuello RR et al. Apoptosis predominates in nonmyocytes in heart failure. Am J Physiol Heart Circ Physiol 2009;297: H785-H791.
40. Yu R, Schellhorn HE. Recent applications of engineered animal antioxidant deficiency models in human nutrition and chronic disease. J Nutr 2013;143:1-11.
41. Jung KJ, Ishigami A, Maruyama N, Takahashi R, Goto S, Yu BP et al. Modulation of gene expression of SMP-30 by LPS and calorie restriction during aging process. Exp Gerontol 2004;39:1169-1177.
42. Inuzuka Y, Okuda J, Kawashima T, KatoT, Niizuma S, TamakiYet al. Suppression of phosphoinositide 3-kinase prevents cardiac aging in mice. Circulation 2009;120:1695-1703.
43. Maejima Y, Adachi S, Ito H, Hirao K, Isobe M. Induction of premature senescence in cardiomyocytes by doxorubicin as a novel mechanism of myocardial damage. Aging Cell 2008;7:125-136.